PageOverview.com
 

Websites hosted on 206.16.26.103

Server (IP 206.16.26.103) has hosted these websites/domains at one point or another.

 
Number of websites/domains displayed: 24
Results found: 24
 

Websites discovered:

Shire UK -     Welcome to Shire Pharmaceuticals UK
http://pageoverview.com/website-report/shirepharmaceuticals.co.uk
  • Renew date: February 8th in 2018
  • Google Analytics: 27662357-1
Xiidra® (lifitegrast ophthalmic solution) 5% for Dry Eye Disease
http://pageoverview.com/website-report/xiidra.com
Discover Xiidra ®, used for the treatment of the signs and symptoms of dry eye disease. Most common side effects include eye irritation, discomfort or blurred vision when drops are applied to the eyes, and an unusual taste sensation.
  • Expected expiration: August 26th in 2017
  • Creation date: August 26th in 2013
  • Renew date: July 30th in 2016
ADHD & You is Dedicated to Helping You
http://pageoverview.com/website-report/keepmomming.com
Whether you have ADHD or you care for someone that does, ADHD & You is dedicated to supporting you with tips, resources, and more.
  • Expected expiration: October 23rd in 2017
  • Creation date: October 23rd in 2013
  • Renew date: September 26th in 2016
PENTASA® (mesalamine) Official Web Site
http://pageoverview.com/website-report/pentasaus.com
  • Expected expiration: July 22nd in 2018
  • Creation date: July 22nd in 2003
  • Renew date: June 25th in 2017
Fabry Disease | Fabry Awareness
http://pageoverview.com/website-report/fabryawareness.com
Healthcare practitioners: Learn about symptoms, signs, management, and other aspects of Fabry Disease and help us raise awareness of this condition.
  • Expected expiration: July 26th in 2018
  • Creation date: July 26th in 2016
  • Renew date: June 29th in 2017
Ulcerative Colitis (UC) Treatment | Lialda® (mesalamine)
http://pageoverview.com/website-report/lialda.com
Check out Lialda for induction of remission in active mild to moderate UC and maintenance of UC remission. Read safety info including potential kidney problems.
  • Expected expiration: June 20th in 2018
  • Creation date: June 20th in 2005
  • Renew date: May 24th in 2017
Xiidra® (lifitegrast ophthalmic solution) 5% Official ECP Site
http://pageoverview.com/website-report/xiidra-ecp.com
Discover Xiidra® (lifitegrast ophthalmic solution) 5%, indicated to treat both the signs and symptoms of Dry Eye Disease. See Safety and Prescribing Info.
  • Expected expiration: May 13th in 2018
  • Creation date: May 13th in 2016
  • Renew date: April 16th in 2017
Home | Shire 2017 ADHD Scholarship Program
http://pageoverview.com/website-report/shireadhdscholarship.com
  • Expected expiration: April 19th in 2018
  • Creation date: April 19th in 2011
  • Renew date: March 23rd in 2017
  • Google Analytics: 26122091-1
shirecontent.com
http://pageoverview.com/website-report/shirecontent.com
  • Expected expiration: September 29th in 2017
  • Creation date: September 29th in 2009
  • Renew date: September 2nd in 2016
CINRYZE® (C1 esterase inhibitor [human])
http://pageoverview.com/website-report/cinryze.com
  • Expected expiration: April 3rd in 2018
  • Creation date: April 3rd in 2007
  • Renew date: March 8th in 2017
Eu Foco
http://pageoverview.com/website-report/eufoco.com.br
This site is for anyone who might be affected by ADHD or who cares for someone who does. Remember, you are not alone and here you will find what living ADHD looks like by understanding what ADHD is, what its symptoms are, and how it is diagnosed.
  • Expected expiration: February 28th in 2019
  • Creation date: February 28th in 2016
  • Renew date: January 29th in 2018
  • Google Analytics: 72439429-3
ONCASPAR® (pegaspargase)
http://pageoverview.com/website-report/oncaspar.com
ONCASPAR (pegaspargase) is given to patients with acute lymphoblastic leukemia (ALL) as part of a group of chemotherapy medications. ONCASPAR works by starving leukemia cells of the nutrients they need to thrive.
  • Expected expiration: October 21st in 2020
  • Creation date: October 21st in 2008
  • Renew date: September 13th in 2016
  • Google Analytics: 73262557-1
ADYNOVATE® [Antihemophilic Factor (Recombinant), PEGylated] Official Site
http://pageoverview.com/website-report/adynovate.com
The official site for ADYNOVATE. Please see ADYNOVATE Detailed Important Risk Information and full Prescribing Information.
  • Expected expiration: March 10th in 2018
  • Creation date: March 10th in 2015
  • Renew date: March 6th in 2017
Home
http://pageoverview.com/website-report/adhs-zukunftstraeume.de
  • Renew date: July 8th in 2015
  • Google Analytics: 27662357-1
intuniv.com
http://pageoverview.com/website-report/intuniv.com
  • Expected expiration: June 15th in 2017
  • Creation date: June 15th in 2002
  • Renew date: May 19th in 2016
CPAMM The Coalition to Prevent ADHD Medication Misuse
http://pageoverview.com/website-report/cpamm.org
    Official Site for ADVATE® [Antihemophilic Factor (Recombinant)]
    http://pageoverview.com/website-report/advate.com
    Learn about ADVATE. Please see the ADVATE Detailed Important Risk Information and full Prescribing Information.
    • Expected expiration: June 3rd in 2024
    • Creation date: June 3rd in 2002
    • Renew date: September 1st in 2016
    Vyvanse® (lisdexamfetamine dimesylate) CII for moderate to severe B.E.D. in adults & ADHD
    http://pageoverview.com/website-report/shireadhd.com
    Information about a treatment for ADHD and moderate to severe binge eating disorder in adults. Limitation against use for weight loss. See Important Safety Info & Boxed Warning about Abuse and Dependence.
    • Expected expiration: June 20th in 2018
    • Creation date: June 20th in 2007
    • Renew date: May 24th in 2017
    Shire Hematology Support| Hematology Resources & Copay Assistance
    http://pageoverview.com/website-report/hematologysupport.com
    Living with hemophilia or von Willebrand disease? Explore Shire Hematology Support to learn about treatment trial programs and copay assistance.
    • Expected expiration: July 8th in 2018
    • Creation date: July 8th in 2015
    • Renew date: July 4th in 2017
    Vyvanse® (lisdexamfetamine dimesylate) CII - HCP Site
    http://pageoverview.com/website-report/vyvansepro.com
    An ADHD and moderate to severe B.E.D in adults treatment. Limitation against use for weight loss. See Important Safety Info & Boxed Warning about Abuse and Dependence.
    • Expected expiration: April 21st in 2018
    • Creation date: April 21st in 2009
    • Renew date: March 25th in 2017
    FIRAZYR® (icatibant injection)
    http://pageoverview.com/website-report/firazyr.com
    The official website of FIRAZYR® (icatibant injection) by Shire. Learn more about associated risks and benefits, including important safety information.
    • Expected expiration: November 22nd in 2018
    • Creation date: November 22nd in 2005
    • Renew date: October 30th in 2017
    Jennifer Aniston’s chronic dry eye story | it’s time for eyelove®
    http://pageoverview.com/website-report/myeyelove.com
    Hear about Jen’s Chronic Dry Eye story. Find out if it is time to chat with your Eye Doctor and get the scoop on Chronic Dry Eye.
    • Expected expiration: October 1st in 2017
    • Creation date: October 1st in 2015
    • Renew date: September 4th in 2016
    GATTEX® (teduglutide [rDNA origin]) for Injection
    http://pageoverview.com/website-report/gattex.com
    GATTEX® is a prescription medicine for adults with Short Bowel Syndrome who need additional nutrition or fluids from IV feeding. See Serious Side Effects.
    • Expected expiration: January 13th in 2021
    • Creation date: January 13th in 2005
    • Renew date: May 29th in 2016
    Vyvanse® (lisdexamfetamine dimesylate) Copay Information
    http://pageoverview.com/website-report/vyvansecopay.com
    Find your copay information. See Important Safety Info & Warning regarding Potential for Abuse and Dependence.
    • Expected expiration: November 8th in 2018
    • Creation date: November 8th in 2013
    • Renew date: October 12th in 2017
    0.2570 // 2024-05-04 06:44:06
    All Rights reserved 2018 © PageOverview.com